Gain a better understanding of MCL-1, specifically focused on #cancer, and its role in solid vs. #hematological #tumors. All of this leads to an update on (pre)clinical development programs of state-of-the-art #MCL1 targeting compounds. https://t.co/XMXnQb
RT @BioMedCentral: A Review published in the Journal of Hematology & Oncology found that myeloid cell leukemia-1 inhibitors may become the…
A Review published in the Journal of Hematology & Oncology found that myeloid cell leukemia-1 inhibitors may become the next novel class of anti-tumor agents with considerable potential across different malignancies. https://t.co/oOGw1bBDgp
Bolomsky, A.-MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. https://t.co/EC3JCfmZVT #OA